Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
5 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
6 days ago
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.

Girls more likely to show complete response to EoE treatment

08 Oct 2019

Girls with eosinophilic oesophagitis (EoE) who show initial response to directed therapy will tend to continue to respond well to treatment, a recent study has shown.

Prospectively enrolling 146 children with EoE (mean age at diagnosis, 7.23±4.88 years; 70.5 percent male) into a database, researchers assessed longitudinal patterns of response to treatment. Among the information collected were patient demographics, allergy test results, symptoms, medication compliance, endoscopic results and histologic findings.  

Multivariate regression analysis showed that girls were significantly more likely to show continuous positive response to treatment, defined as having less than 15 eosinophils/hpf in at least 75 percent of follow-up biopsies (odds ratio [OR], 2.95, 95 percent CI, 1.26–7.14; p=0.014). Initial complete response to therapy was also significantly predictive of a sustained response (OR, 9.97, 4.20–26.81; p<0.001).

Aside from complete responders, researchers also identified two other distinct patterns of treatment response: intermittent responders, who had clear biopsies 25–75 percent of the time, and nonresponders, whose biopsies were clear only <25 percent of the time.

Patients in the distinct response trajectories had different characteristics. Intermittent responders, for instance, were more likely to have allergic rhinitis, while complete responders tended to have lower body mass indices. Initial response to proton pump inhibitors also predicted complete response, though this effect was attenuated upon multivariate adjustments.

“It will be interesting to understand whether our findings are broadly applicable to the EoE population because defining optimal chronic EoE management is a pressing need, especially in children,” said researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
5 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
6 days ago
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.